FIELD: medicine.
SUBSTANCE: present invention relates to cardiology. Method for treating atrial enlargement and/or preventing or delaying a first atrial fibrillation in a patient having heart failure with a preserved ejection fraction (HF-PEF), comprising administrating a prodrug of the NEP inhibitor which is N-(3-carboxy-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methylbutanoic acid ethyl ester or a pharmaceutically acceptable salt thereof, wherein the prodrug of the NEP inhibitor is delivered by the administration of LCZ696, which is trisodium [3-((1S, 3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3'-methyl-2'-(pentanoyl{2"-(tetrazol-5-yl)biphenyl-4'-ylmethyl}amino)butyrate]hemi-pentahydrate, in an initial dose of 50 mg twice a day, gradually changing to a final dose of 200 mg twice a day for a period of 36 weeks, to a patient in need of such treatment.
EFFECT: method provides a reduced level of NT-proBNP in plasma, reduced frequency of atrial fibrillation in the treatment of said group of patients.
4 cl, 1 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
NEP INHIBITORS FOR TREATMENT OF DISEASES CHARACTERIZED BY ATRIAL ENLARGEMENT OR REMODELING | 2018 |
|
RU2809222C2 |
PHARMACEUTICAL COMPOSITIONS INCLUDING VALSARTAN AND INHIBITORS OF NEUTRAL ENDOPEPTITAS (NEP) | 2003 |
|
RU2334513C2 |
TREATMENT OF HYPERTENSION AND/OR PREVENTION AND TREATMENT OF HEART FAILURE IN MAMMAL, RECEIVING ANTICOAGULANT THERAPY | 2011 |
|
RU2564941C2 |
METHOD OF PRODUCING INTERMEDIATE COMPOUNDS FOR PREPARING NEP INHIBITORS | 2011 |
|
RU2588572C2 |
PHARMACEUTICAL COMBINATIONS OF ANGIOTENSIN RECEPTOR ANTAGONIST AND NEP INHIBITOR | 2006 |
|
RU2503668C2 |
PHARMACEUTICAL COMBINATIONS OF ANGIOTENSINE RECEPTOR ANTAGONIST AND NEP INHIBITOR | 2006 |
|
RU2459809C2 |
NEW METHOD AND NEW INTERMEDIATE COMPOUNDS | 2016 |
|
RU2769445C2 |
GALENIC COMPOSITIONS OF ORGANIC COMPOUNDS | 2017 |
|
RU2773029C2 |
NOVEL METHOD FOR OBTAINING INTERMEDIATE COMPOUNDS, APPLIED IN OBTAINING NEP INHIBITORS | 2011 |
|
RU2573824C2 |
SUBSTITUTED DERIVATIVES OF BISPHENYL ESTER OF BUTYRIC ACID AS NEP INHIBITORS | 2019 |
|
RU2784522C2 |
Authors
Dates
2018-09-21—Published
2013-08-22—Filed